|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||153.78 - 154.70|
|52-week range||153.78 - 154.70|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||47.98|
|Earnings date||27 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
BOTHELL, Wash., September 09, 2021--Seagen Inc. (Nasdaq: SGEN) today announced that management will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 2:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at www.seagen.com in the Investors section.
BOTHELL, Wash., September 08, 2021--Seagen Inc. (Nasdaq: SGEN) today announced data and trials in progress from its diverse and growing portfolio of marketed and investigational therapies will be presented at the virtual European Society for Medical Oncology (ESMO) 2021 Annual Meeting, to be held from September 16-21. Sixteen presentations will demonstrate the breadth of Seagen’s portfolio and development activities, across multiple cancer types - including a mini oral presentation featuring res
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...